Vicki Kelemen Cardiff Oncology, Inc. (CRDF) insider trading activity

CRDF Quotes by TradingView

Vicki Kelemen is Exec. VP and COO of Cardiff Oncology, Inc.. Currently has a direct ownership of 6,053 shares of CRDF, which is worth approximately $16,403. The most recent transaction as insider was on Mar 23, 2021, when has been sold 960 shares (Common Stock) at a price of $10.31 per share, resulting in proceeds of $9,898. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.05K
0% 3M change
0% 12M change
Total Value Held $16,403

Vicki Kelemen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 23 2021
BUY
Open market or private purchase
$9,898 $10.31 p/Share
960 Added 13.69%
6,053 Common Stock
Jan 02 2021
SELL
Payment of exercise price or tax liability
-
31 Reduced 0.6%
5,093 Common Stock
Jan 02 2021
BUY
Exercise of conversion of derivative security
-
70 Added 1.35%
5,124 Common Stock
Nov 23 2020
SELL
Open market or private sale
$656,971 $18.6 p/Share
35,321 Reduced 87.48%
5,054 Common Stock
Nov 23 2020
BUY
Exercise of conversion of derivative security
$87,596 $2.48 p/Share
35,321 Added 46.66%
40,375 Common Stock
VK

Vicki Kelemen

Exec. VP and COO
San Diego, CA

Track Institutional and Insider Activities on CRDF

Follow Cardiff Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRDF shares.

Notify only if

Insider Trading

Get notified when an Cardiff Oncology, Inc. insider buys or sells CRDF shares.

Notify only if

News

Receive news related to Cardiff Oncology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRDF